MUC16 and cancer: The UK National Institute for Health and Care Excellence (NICE) guidelines for cancer detection (NG12) recommend women presenting in primary care with symptoms of possible OC be tested for CA125, followed by pelvic USS if CA125 ≥ 35 U/mL [7].